Forbes
NEW YORK - Drug maker Pfizer Inc. is reportedly planning to stop developing drugs for heart disease, obesity and bone health to focus on more profitable fields such as treatments for cancer and Alzheimer's disease.
New York-based Pfizer (nyse: PFE - news - people )'s products include the cholesterol drug Lipitor, the world's top-selling pharmaceutical product with quarterly sales of $3 billion. The Wall Street Journal reported that Pfizer will complete development of late stage drug candidates for those diseases.....read the whole story
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment